Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases.

MLA

Kimura, S. I., et al. “Economic Evaluation of a Preemptive Treatment Strategy for Invasive Fungal Infection in Neutropenic Patients with Hematological Diseases.” European Journal of Clinical Microbiology & Infectious Diseases, vol. 34, no. 5, May 2015, pp. 951–61. EBSCOhost, https://doi.org/10.1007/s10096-014-2311-8.

APA

Kimura, S.-I., Murata, T., Akahoshi, Y., Nakano, H., Ugai, T., Wada, H., Yamasaki, R., Ishihara, Y., Kawamura, K., Sakamoto, K., Ashizawa, M., Sato, M., Terasako-Saito, K., Nakasone, H., Kikuchi, M., Yamazaki, R., Kako, S., Kanda, J., Tanihara, A., & Nishida, J. (2015). Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases. European Journal of Clinical Microbiology & Infectious Diseases, 34(5), 951–961. https://doi.org/10.1007/s10096-014-2311-8

Chicago

Kimura, S.-I., T. Murata, Y. Akahoshi, H. Nakano, T. Ugai, H. Wada, R. Yamasaki, et al. 2015. “Economic Evaluation of a Preemptive Treatment Strategy for Invasive Fungal Infection in Neutropenic Patients with Hematological Diseases.” European Journal of Clinical Microbiology & Infectious Diseases 34 (5): 951–61. doi:10.1007/s10096-014-2311-8.